Glaxosmithkline Stock Forecast

Buy or Hold candidate since Sep 26, 2025 Gain 19.27%

The GlaxoSmithKline stock price gained 0.742% on the last trading day (Monday, 17th Nov 2025), rising from $47.18 to $47.53. During the last trading day the stock fluctuated 1.17% from a day low at $47.42 to a day high of $47.98. The price has risen in 6 of the last 10 days and is up by 2.55% over the past 2 weeks. Volume fell on the last day by -990 thousand shares and in total, 4 million shares were bought and sold for approximately $177.52 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 22.85% during the next 3 months and, with a 90% probability hold a price between $55.02 and $60.17 at the end of this 3-month period.

GSK Signals & Forecast

The GlaxoSmithKline stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $47.61. On a fall, the stock will find some support from the long-term average at approximately $45.17. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, November 11, 2025, and so far it has fallen -1.82%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for GlaxoSmithKline stock

GlaxoSmithKline finds support from accumulated volume at $45.51 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.555 between high and low, or 1.17%. For the last week, the stock has had daily average volatility of 1.32%.

Our recommended stop-loss: $45.80 (-3.64%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (GSK) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect GlaxoSmithKline PLC to open at $47.64, and during the day (based on 14 day Average True Range), to move between $47.04 and $48.02, which gives a possible trading interval of +/-$0.97 (+/-2.07%) up or down from last closing price. If GlaxoSmithKline PLC takes out the full calculated possible swing range there will be an estimated 2.07% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $48.07 (1.14%) than the support at $45.51 (4.25%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is GlaxoSmithKline PLC stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for GlaxoSmithKline stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.202 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $47.64 ( 0.235%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk